1. GA101 induces NK-cell activation and antibody-dependent cellular cytotoxicity more effectively than rituximab when complement is present. Issue 11 (November 2013) Authors: Kern, Delila J.; James, Britnie R.; Blackwell, Sue; Gassner, Christian; Klein, Christian; Weiner, George J. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. (May 2018) Authors: Kim, Hyunjoon; Niu, Lin; Larson, Peter; Kucaba, Tamara A.; Murphy, Katherine A.; James, Britnie R.; Ferguson, David M.; Griffith, Thomas S.; Panyam, Jayanth Journal: Biomaterials Issue: Volume 164(2018) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma. (18th October 2015) Authors: Brincks, Erik L.; Kucaba, Tamara A.; James, Britnie R.; Murphy, Katherine A.; Schwertfeger, Kathryn L.; Sangwan, Veena; Banerjee, Sulagna; Saluja, Ashok K.; Griffith, Thomas S. Journal: FEBS journal Issue: Volume 282:Number 24(2015) Page Start: 4747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗